Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort

被引：0

作者：

Fabrice Carrat

Julie Figoni

Joseph Henny

Jean-Claude Desenclos

Sofiane Kab

Xavier de Lamballerie

Marie Zins

机构：

[1] Sorbonne Université,APHP, Département de Santé Publique, Inserm, Institut Pierre

[2] Santé publique France,Louis d’Epidémiologie et de Santé Publique

[3] Paris University,Inserm UMS 11

[4] Paris Saclay University,Unité des Virus Emergents

[5] Aix Marseille Univ,undefined

[6] IRD 190,undefined

[7] INSERM 1207,undefined

[8] IHU Méditerranée Infection,undefined

来源：

European Journal of Epidemiology | 2021年 / 36卷

关键词：

SARS-CoV-2; COVID-19; General population; Cohort;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Using serum samples routinely collected in 9144 adults from a French general population-based cohort, we identified 353 participants with a positive anti-SARS-CoV-2 IgG test, among whom 13 were sampled between November 2019 and January 2020 and were confirmed by neutralizing antibodies testing. Investigations in 11 of these participants revealed experience of symptoms possibly related to a SARS-CoV-2 infection or situations at risk of potential SARS-CoV-2 exposure. This suggests early circulation of SARS-CoV-2 in Europe.

引用

页码：219 / 222

页数：3

共 32 条

[1]

Deslandes A(2020)SARS-CoV-2 was already spreading in France in late December 2019 Int J Antimicrob Agents 55 106006-1328

[2]

Berti V(2020)Hospital and population-based evidence for COVID-19 early circulation in the East of France Int J Environ Res Public Health 17 7175-1394

[3]

Tandjaoui-Lambotte Y(2021)SARS-CoV-2 has been circulating in northern Italy since December 2019: evidence from environmental monitoring Sci Total Environ 750 141711-undefined

[4]

Alloui C(2015)The French CONSTANCES population-based cohort: design, inclusion and follow-up Eur J Epidemiol 30 1317-undefined

[5]

Carbonnelle E(2020)Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors Antiviral Res 181 104880-undefined

[6]

Zahar JR(2020)Validation of a commercially available SARS-CoV-2 serological immunoassay Clin Microbiol Infect 26 1386-undefined

[7]

Gerbaud L(undefined)undefined undefined undefined undefined-undefined

[8]

Guiguet-Auclair C(undefined)undefined undefined undefined undefined-undefined

[9]

Breysse F(undefined)undefined undefined undefined undefined-undefined

[10]

Odoul J(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 4 →